ID

30353

Beschreibung

https://clinicaltrials.gov/ct2/show/NCT00486954 Study ID: 104578 Clinical Study ID: EGF104578 Study Title: A Randomized, Multicenter, Open-label, Phase III Study of Lapatinib (GW572016) in Combination with weekly Paclitaxel versus weekly Paclitaxel alone in the second line treatment of ErbB2 amplified Advanced Gastric Cancer Patient Level Data: Clinicaltrials.gov Identifier: NCT00486954 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Product Sponsorship Transferred to Novartis Generic Name: lapatinib Trade Name: Tyverb,Tykerb,Tycerb Study Indication: Neoplasms, Gastrointestinal Tract CRF Seiten: 1288-1609

Link

https://clinicaltrials.gov/ct2/show/NCT00486954

Stichworte

Versionen (1)
  1. 29.05.18 29.05.18 - Halim Ugurlu
Rechteinhaber

GlaxoSmithKline (GSK)

Hochgeladen am

29. Mai 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

NCT00486954_Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer

Englisch

Safety Assessment of Interstitial Pneumonitis, Continutation, Status, Concominant Medications

1 Formulare  
Safety Assessment of Interstitial Pneumonitis
Beschreibung

Safety Assessment of Interstitial Pneumonitis

Alias
UMLS CUI-1
C0206061
Was a chest CT, MRI or x-ray performed as surveillance for interstitial pneumonitis?
Beschreibung

If yes, record any findings in teh Adverse Events or Serious Adverse Events from as appropriate

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0206061
UMLS CUI [1,2]
C0920316
UMLS CUI [1,3]
C0733511
UMLS CUI [1,4]
C0011923
Continutation
Beschreibung

Continutation

Alias
UMLS CUI-1
C0805733
Will the subject start the next cycle?
Beschreibung

Continutation

Datentyp

boolean

Alias
UMLS CUI [1]
C0805733
Status
Beschreibung

Status

Alias
UMLS CUI-1
C0449438
Were any concominant medications taken by the subject prior to screening and/or during study?
Beschreibung

concominant medication

Datentyp

boolean

Alias
UMLS CUI [1]
C2347852
Did the subject experience any non-serious adverse events during the study?
Beschreibung

non-serious adverse events during the study

Datentyp

boolean

Alias
UMLS CUI [1]
C1518404
Did the subject experience any serious adverse events during the study?
Beschreibung

Serious adverse events during the study

Datentyp

boolean

Alias
UMLS CUI [1]
C1519255
Were any blood products or blood supportive care products used for the subject prior to screening and/or during study?
Beschreibung

Blood products or blood supportive care products use

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0456388
UMLS CUI [1,2]
C0457083
Concominant Medications
Beschreibung

Concominant Medications

Alias
UMLS CUI-1
C2347852
Drug name
Beschreibung

Trade name preferred

Datentyp

text

Alias
UMLS CUI [1]
C2360065
Reason for medication
Beschreibung

Reason for medication

Datentyp

text

Alias
UMLS CUI [1]
C2826696
Start Date
Beschreibung

Start Date

Datentyp

date

Alias
UMLS CUI [1]
C0808070
Taken prior to study?
Beschreibung

Taken prior to study?

Datentyp

boolean

Alias
UMLS CUI [1]
C2826667
Ongoing?
Beschreibung

Ongoing

Datentyp

boolean

Alias
UMLS CUI [1]
C2826666
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Safety Assessment of Interstitial Pneumonitis, Continutation, Status, Concominant Medications

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Safety Assessment of Interstitial Pneumonitis
C0206061 (UMLS CUI-1)
CT, MRI or x-ray performed as surveillance for interstitial pneumonitis
Item
Was a chest CT, MRI or x-ray performed as surveillance for interstitial pneumonitis?
boolean
C0206061 (UMLS CUI [1,1])
C0920316 (UMLS CUI [1,2])
C0733511 (UMLS CUI [1,3])
C0011923 (UMLS CUI [1,4])
Item Group
Continutation
C0805733 (UMLS CUI-1)
Continutation
Item
Will the subject start the next cycle?
boolean
C0805733 (UMLS CUI [1])
Item Group
Status
C0449438 (UMLS CUI-1)
concominant medication
Item
Were any concominant medications taken by the subject prior to screening and/or during study?
boolean
C2347852 (UMLS CUI [1])
non-serious adverse events during the study
Item
Did the subject experience any non-serious adverse events during the study?
boolean
C1518404 (UMLS CUI [1])
Serious adverse events during the study
Item
Did the subject experience any serious adverse events during the study?
boolean
C1519255 (UMLS CUI [1])
Blood products or blood supportive care products use
Item
Were any blood products or blood supportive care products used for the subject prior to screening and/or during study?
boolean
C0456388 (UMLS CUI [1,1])
C0457083 (UMLS CUI [1,2])
Item Group
Concominant Medications
C2347852 (UMLS CUI-1)
Drug name
Item
Drug name
text
C2360065 (UMLS CUI [1])
Reason for medication
Item
Reason for medication
text
C2826696 (UMLS CUI [1])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1])
Taken prior to study?
Item
Taken prior to study?
boolean
C2826667 (UMLS CUI [1])
Ongoing
Item
Ongoing?
boolean
C2826666 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video